Clinical Trial Update: Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults [Phase 1]

View source ↗

Summary

Phase 1 trial updates Entospletinib as monotherapy and in combination with chemotherapy in Japanese adults with hematologic malignancies, including acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hematologic Malignancy

Drugs mentioned

• Entospletinib (entospletinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Hematologic Malignancy, Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2020-03-06